SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
ACADIA Pharmaceuticals Inc (ACAD)
An SI Board Since April 2004
Posts SubjectMarks Bans Symbol
588 32 0 ACAD
Emcee:  michael_f_murphy Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
63FWIW, The seller at $6.80 using inet would seem to have more than 100s availablkeokalani'nui-12/10/2004
62Ah. I was reading the most recent 10-Qs to see if there was any mention. Arqulatticus4paws-12/10/2004
61from the 2003 Arqule 10-K..... ACADIA Pharmaceuticals. On December 18, 2000,scaram(o)uche-12/10/2004
60Yup. Lasts until 12/05, according to the S-1. Anybody have newer news??scaram(o)uche-12/10/2004
59Do Acadia and Arqule still have a business relationship? <eom>atticus4paws-12/10/2004
58the original Arqule release...... Message 13687016 and the birth announcement scaram(o)uche-12/10/2004
57Message 14692239 The nomenclature given by Hacksell, recent presentation descriscaram(o)uche-12/10/2004
56To answer my own question, I'm pretty certain that it is not "the"scaram(o)uche-12/10/2004
55Message 20833523 Message 20833861mopgcw-12/6/2004
54Message 20829639 Message 20829173mopgcw-12/5/2004
53<i> some erosion in anticipation of lockup, but no bargain once it hit??..mopgcw-12/5/2004
52Do we know if the NPFF2 receptor is the target (or one of the targets) for the Ascaram(o)uche-12/5/2004
51some erosion in anticipation of lockup, but no bargain once it hit??...... finascaram(o)uche-12/5/2004
50Message 20827380 Message 20828416mopgcw-12/5/2004
49Neuroreport. 2004 Sep 15;15(13):2071-5. Stimulation of PAR-2 excites and sensiscaram(o)uche-11/10/2004
48biotech jim has been trying to describe it to us for years. I still don't gscaram(o)uche-11/10/2004
47Inverse agonists for therapy (such as AC-103) are rather rare, I gather. I had tuck-11/10/2004
46nothing like giving you your list of search terms.... <i>ACADIA scientistscaram(o)uche-11/10/2004
45ACADIA Pharmaceuticals Reports Third Quarter 2004 Financial Results Wednesday Noscaram(o)uche-11/10/2004
44Piper: ACAD :Partner Allergan Files IND For Neuropathic Pain October 27, 2004mopgcw-10/29/2004
43I am waiting for lockup...mopgcw-10/28/2004
42Man, talk about a wimp seller. Guy must really need money? You could virtuallyscaram(o)uche-10/28/2004
41>> filed an Investigational New Drug application << Hope these guysscaram(o)uche-10/26/2004
40ACADIA Pharmaceuticals Earns Milestone on Advancement of Neuropathic Pain Drug Tscaram(o)uche-10/26/2004
39Another OLD PR: ArQule and ACADIA Pharmaceuticals Establish new Drug Discovermopgcw-9/30/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News